Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1824)	10/2/2007 12:58:53 PM
From: Jibacoa	Read Replies (2) of 3722

In spite of its lower revenues, ISIS has trimmed some of its losses & the stock is up > 50% from its Aug 6 L of 9.52 <g> bigcharts.marketwatch.com Today it announced that it received approval from antitrust regulators to collaborate with a JNJ unit and received a $5M milestone payment from JNJ. ISIS has granted JNJ's Ortho-McNeil worldwide rights to its ISIS 325568 & ISIS 377131. Also, Ortho-McNeil will give Isis funding to support the joint discovery of new treatments for metabolic diseases, including diabetes and obesity. The payment from JNJ was for the start of a PI on ISIS 325568. The stock is trading above its Nov 2006 H, but has some way to go before it can test its Nov 2001 H at 27.15 or its March 2000 at 39 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next